Posts
April 15 2025
Can-Fite Biopharma Ltd. announced the closing of its Registered Direct Offering in the amount of $3,000,000. EG&S acted as counsel to the Placement Agent.
April 14 2025
Venus Concept Inc. announced the closing of its Registered Direct Offering in the amount of $1,500,000. EG&S acted as counsel to the Placement Agent.
April 10 2025
Immunic, Inc. announced the closing of its Registered Direct Offering in the amount of $5,100,000. EG&S acted as counsel to the Placement Agent.
April 10 2025
Venus Concept Inc. announced the closing of its Registered Direct Offering in the amount of $1,100,000. EG&S acted as counsel to the Placement Agent.
April 07 2025
NeuroOne Medical Technologies Corporation announced the closing of its Underwritten Public Offering in the amount of $8,000,000. EG&S acted as counsel to the Underwriter.
April 07 2025
Mobix Labs, Inc. announced the closing of its Registered Direct Offering in the amount of $4,000,000. EG&S acted as counsel to the Placement Agent.
April 04 2025
Aptevo Therapeutics Inc. announced the closing of its Registered Direct Offering and concurrent Private Placement in the amount of $2,100,000. EG&S acted as counsel to the Placement Agent.
April 03 2025
Client Alert: New EEOC Guidance Addressing DEI-Related Discrimination in the Workplace
The Equal Employment Opportunity Commission (“EEOC”), jointly with the U.S. Department of Justice (“DOJ”), issued two technical assistance documents addressing DEI-related discrimination in the workplace. The EEOC released a document entitled “What You Should Know About DEI-Related Discrimination at Work” in a question-and-answer format and the EEOC and DOJ jointly issued a one-page document entitled “What To Do If You Experience Discrimination Related to DEI at Work.”
Click here to read the alert.